Cosmo Pharmaceuticals
C43.F
$77.61
Share price
-2.68%
Change (1 day)
30.92%
Change (1 year)
Categories
EPS for Cosmo Pharmaceuticals (C43.F)
EPS in 2022: $1.12
According to Cosmo Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.12. In 2022 the company made an earnings per share (EPS) of $1.12 a decrease over its 2021 EPS that were of $1.46.
EPS history for Cosmo Pharmaceuticals from 2004 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | $1.12 | -22.92% |
| 2021 | $1.46 | -317.03% |
| 2020 | -$0.67 | -64.08% |
| 2019 | -$1.87 | 36.19% |
| 2018 | -$1.37 | -47.81% |
| 2017 | -$2.63 | -282.25% |
| 2016 | $1.44 | -92.5% |
| 2015 | $19.24 | 209.32% |
| 2014 | $6.22 | -6.29% |
| 2013 | $6.64 | 255.93% |
| 2012 | $1.87 | 173.6% |
| 2011 | $0.68 | 107.49% |
| 2010 | $0.33 | -22.27% |
| 2009 | $0.42 | -55.54% |
| 2008 | $0.95 | 7392.2% |
| 2007 | $0.01269 | -124.39% |
| 2006 | -$0.05203 | -113.4% |
| 2005 | $0.39 | -129.97% |
| 2004 | -$1.30 |